Trial · NCT02641340
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Maximum concentration (Cmax) | within 24 hours (see detailed description) | |
| Primary | Time to reach peak or maximum concentration following drug administration (Tmax) | within 24 hours (see detailed description) | |
| Primary | Area under the concentration-time curve | within 24 hours (see detailed description) | Categories: during a dosing interval (AUCtau ), from the time of dosing to infinity (AUC0-inf), from the time of dosing to the last quantifiable time point (AUC0-t) |
| Primary | Apparent elimination rate constant in the terminal phase by non-compartmental analysis | within 24 hours (see detailed description) | |
| Primary | Corresponding half-life (t1/2) | within 24 hours (see detailed description) | |
| Primary | Trough concentration during multiple dosing prior to next dose (Ctrough) | within 24 hours (see detailed description) | |
| Primary | Accumulation ratios | within 24 hours (see detailed description) | Categories: of Cmax (ARcmax), based on trough concentration (ARctrough), of AUCtau (ARauctau) |
| Primary | Dose normalized Cmax | within 24 hours (see detailed description) | |
| Primary | Dose normalized AUC | within 24 hours (see detailed description) | Categories: AUC0-1, AUC0-inf, AUCtau |
| Secondary | Participants with respiratory depression requiring the use of naloxone | within 24 hours | |
| Secondary | Participants with hypoxia requiring oxygen administration | within 24 hours | |
| Secondary | Participants needing noninvasive respiratory maneuvers (e.g., jaw thrust, bag-valve mask) to improve respiratory status at any point during the study | within 24 hours | |
| Secondary | Participants with hypotension requiring intervention | within 24 hours |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02641340/registered